Cargando…

The Role of Tau beyond Alzheimer’s Disease: A Narrative Review

Nowadays, there is a need for reliable fluid biomarkers to improve differential diagnosis, prognosis, and the prediction of treatment response, particularly in the management of neurogenerative diseases that display an extreme variability in clinical phenotypes. In recent years, Tau protein has been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Virgilio, Eleonora, De Marchi, Fabiola, Contaldi, Elena, Dianzani, Umberto, Cantello, Roberto, Mazzini, Letizia, Comi, Cristoforo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026415/ https://www.ncbi.nlm.nih.gov/pubmed/35453510 http://dx.doi.org/10.3390/biomedicines10040760

Ejemplares similares

Telehealth in Neurodegenerative Diseases: Opportunities and Challenges for Patients and Physicians
por: De Marchi, Fabiola, et al.
Publicado: (2021)

Potential role of vitamin D levels in amyotrophic lateral sclerosis cognitive impairment
por: De Marchi, Fabiola, et al.
Publicado: (2023)

Motor and non-motor symptom improvement after mRNA-1273 vaccine in a Parkinson’s disease patient
por: Contaldi, Elena, et al.
Publicado: (2021)

Variability in Clinical Phenotype in TARDBP Mutations: Amyotrophic Lateral Sclerosis Case Description and Literature Review
por: Lombardi, Michele, et al.
Publicado: (2023)

Serum Vitamin D as a Marker of Impaired Information Processing Speed and Early Disability in Multiple Sclerosis Patients
por: Virgilio, Eleonora, et al.
Publicado: (2021)

K Index is a Reliable Marker of Intrathecal Synthesis, and an Alternative to IgG Index in Multiple Sclerosis Diagnostic Work-Up
por: Crespi, Ilaria, et al.
Publicado: (2019)

Predicting Cognitive Decline in Parkinson’s Disease: Can We Ask the Genes?
por: De Marchi, Fabiola, et al.
Publicado: (2014)

Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19
por: De Marchi, Fabiola, et al.
Publicado: (2020)

Immune Response Modifications in the Genetic Forms of Parkinson’s Disease: What Do We Know?
por: Magistrelli, Luca, et al.
Publicado: (2022)

Prognostic Role of Visual Evoked Potentials in Non-Neuritic Eyes at Multiple Sclerosis Diagnosis
por: Vecchio, Domizia, et al.
Publicado: (2023)

Susac Syndrome: an uncommon cause of impaired vision
por: Barbero, Paolo, et al.
Publicado: (2022)

Early Predictors of Disability and Cognition in Multiple Sclerosis Patients: A Long-Term Retrospective Analysis
por: Virgilio, Eleonora, et al.
Publicado: (2023)

Expanding the genetic spectrum of primary familial brain calcification due to SLC2OA2 mutations: a case series
por: Magistrelli, Luca, et al.
Publicado: (2021)

The Need for Biomarkers in the ALS–FTD Spectrum: A Clinical Point of View on the Role of Proteomics
por: Vignaroli, Francesca, et al.
Publicado: (2023)

Neurological emergency at the COVID-19 pandemic: report from a referral hospital in Eastern Piedmont, Italy
por: Varrasi, Claudia, et al.
Publicado: (2022)

Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers
por: Tondo, Giacomo, et al.
Publicado: (2022)

Amyotrophic lateral sclerosis progression in the year of the COVID-19 pandemic
por: De Marchi, Fabiola, et al.
Publicado: (2021)

Accelerated Early Progression of Amyotrophic Lateral Sclerosis over the COVID-19 Pandemic
por: De Marchi, Fabiola, et al.
Publicado: (2021)

Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy
por: Fleetwood, Thomas, et al.
Publicado: (2018)

The Impact of SNCA Variations and Its Product Alpha-Synuclein on Non-Motor Features of Parkinson’s Disease
por: Magistrelli, Luca, et al.
Publicado: (2021)

T Lymphocytes in Parkinson’s Disease
por: Contaldi, Elena, et al.
Publicado: (2022)

Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants
por: De Marchi, Fabiola, et al.
Publicado: (2023)

Detection of White Matter Ultrastructural Changes for Amyotrophic Lateral Sclerosis Characterization: A Diagnostic Study from Dti-Derived Data
por: De Marchi, Fabiola, et al.
Publicado: (2020)

Treatment of Chronic Inflammatory Demyelinating Polyneuropathy: From Molecular Bases to Practical Considerations
por: Ripellino, Paolo, et al.
Publicado: (2014)

Exploiting PLGA-Based Biocompatible Nanoparticles for Next-Generation Tolerogenic Vaccines against Autoimmune Disease
por: Cappellano, Giuseppe, et al.
Publicado: (2019)

Striatal dopamine transporter imaging in Parkinson’s disease drug-naïve patients: focus on sexual dysfunction
por: Contaldi, Elena, et al.
Publicado: (2022)

The Yin-Yang of osteopontin in nervous system diseases: damage versus repair
por: Cappellano, Giuseppe, et al.
Publicado: (2020)

Potential protective role of ACE-inhibitors and AT1 receptor blockers against levodopa-induced dyskinesias: a retrospective case-control study
por: Contaldi, Elena, et al.
Publicado: (2021)

Advances in Neuroimmunology: From Bench to Bedside
por: Comi, Cristoforo, et al.
Publicado: (2014)

Lymphocyte Count and Neutrophil-to-Lymphocyte Ratio Are Associated with Mild Cognitive Impairment in Parkinson’s Disease: A Single-Center Longitudinal Study
por: Contaldi, Elena, et al.
Publicado: (2022)

A Telehealth Intervention for Nutritional Counseling in Amyotrophic Lateral Sclerosis Patients
por: De Marchi, Fabiola, et al.
Publicado: (2022)

Intrathecal kappa free light chains as markers for multiple sclerosis
por: Vecchio, D., et al.
Publicado: (2020)

Revisiting the Molecular Mechanism of Neurological Manifestations in Antiphospholipid Syndrome: Beyond Vascular Damage
por: Carecchio, M., et al.
Publicado: (2014)

COVID-19 Vaccination and Late-Onset Myasthenia Gravis: A New Case Report and Review of the Literature
por: Virgilio, Eleonora, et al.
Publicado: (2022)

The PROB-PD trial: a pilot, randomised, placebo-controlled study protocol to evaluate the feasibility and potential efficacy of probiotics in modulating peripheral immunity in subjects with Parkinson’s disease
por: Martini, Stefano, et al.
Publicado: (2023)

Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases
por: Clemente, Nausicaa, et al.
Publicado: (2016)

Expression of Transcription Factors in CD4 + T Cells as Potential Biomarkers of Motor Complications in Parkinson’s Disease
por: Contaldi, Elena, et al.
Publicado: (2021)

Probiotics May Have Beneficial Effects in Parkinson's Disease: In vitro Evidence
por: Magistrelli, Luca, et al.
Publicado: (2019)

The Impact of Osteopontin Gene Variations on Multiple Sclerosis Development and Progression
por: Comi, Cristoforo, et al.
Publicado: (2012)

A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis
por: Di Gioia, Diana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nd3pvftvn6jelucra9f3hq06p5